Opiant Pharmaceuticals Inc insider Kevin Pollack bought 4,820 shares of the stock in a transaction dated Friday, January 13th. The stock was bought at an average cost of $6.98 per share, for a total transaction of $33,643.60.
Opiant Pharmaceuticals Inc insider Kevin Pollack bought 4,820 shares of the stock in a transaction dated Friday, January 13th. The stock was bought at an average cost of $6.98 per share, for a total transaction of $33,643.60.